Literature DB >> 27303172

Targeted Broadband UVB Phototherapy forthe Treatment of Localized Vitiligo.

Jeong Eun Kim1, Hyo Hyun Ahn1, Young Chul Kye1.   

Abstract

BACKGROUND: Several new treatments appear to have higher success rates than previous therapies for the treatment of vitiligo, and targeted phototherapy is an alternative that may prove to be time-efficient and an effective therapeutic option for the management of this condition.
OBJECTIVE: The aim of this study was to evaluate the efficacy of targeted broadband UVB phototherapy for the treatment of localized vitiligo.
METHODS: Fifty-three vitiliginous patches on thirty-five patients (16 males, 19 females) were treated using a targeted broadband UVB phototherapy device. Treatment was started at 70% of the minimal erythema dose, and then gradually increased. Lesions were treated twice a week for a maximum of 60 treatment sessions.
RESULTS: Subjects tolerated treatment well. Forty-one of the fifty-three patches (77.4%) achieved repigmentation on ≤75% of the treated areas. Best results were obtained on the face and neck; 20 of the 24 patches (83.3%) concerned achieved ≤75% repigmentation. The least response was on the hands and feet; 3 of 6 patches (50%) showed ≤75% repigmentation. The results were better for focal type than segmental type vitiligo.
CONCLUSION: Targeted broadband UVB phototherapy appears to be highly effective at restoring pigmentation in patients with localized vitiligo.

Entities:  

Keywords:  Targeted broadband UVB phototherapy; Vitiligo

Year:  2008        PMID: 27303172      PMCID: PMC4903959          DOI: 10.5021/ad.2008.20.3.107

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  20 in total

1.  Treatment of vitiligo with the 308-nm excimer laser: a pilot study.

Authors:  James M Spencer; Robert Nossa; Jyotendra Ajmeri
Journal:  J Am Acad Dermatol       Date:  2002-05       Impact factor: 11.527

2.  Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome.

Authors:  D Parsad; R Pandhi; S Dogra; A J Kanwar; B Kumar
Journal:  Br J Dermatol       Date:  2003-02       Impact factor: 9.302

Review 3.  Management of vitiligo.

Authors:  F Shaffrali; D Gawkrodger
Journal:  Clin Exp Dermatol       Date:  2000-11       Impact factor: 3.470

4.  Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study.

Authors:  Pravit Asawanonda; Marisa Charoenlap; Wiwat Korkij
Journal:  Photodermatol Photoimmunol Photomed       Date:  2006-06       Impact factor: 3.135

5.  Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature.

Authors:  M D Njoo; P I Spuls; J D Bos; W Westerhof; P M Bossuyt
Journal:  Arch Dermatol       Date:  1998-12

6.  Psychologic effects of vitiligo: a critical incident analysis.

Authors:  G Kent; M Al'Abadie
Journal:  J Am Acad Dermatol       Date:  1996-12       Impact factor: 11.527

Review 7.  Evidence for an autoimmune pathogenesis of vitiligo.

Authors:  Katia Ongenae; Nanny Van Geel; Jean-Marie Naeyaert
Journal:  Pigment Cell Res       Date:  2003-04

8.  UV-B radiation microphototherapy. An elective treatment for segmental vitiligo.

Authors:  T M Lotti; G Menchini; L Andreassi
Journal:  J Eur Acad Dermatol Venereol       Date:  1999-09       Impact factor: 6.166

9.  Role of hair follicles in the repigmentation of vitiligo.

Authors:  J Cui; L Y Shen; G C Wang
Journal:  J Invest Dermatol       Date:  1991-09       Impact factor: 8.551

10.  The use of the 308-nm excimer laser for the treatment of vitiligo.

Authors:  Suhail M Hadi; James M Spencer; Mark Lebwohl
Journal:  Dermatol Surg       Date:  2004-07       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.